TY - JOUR
T1 - Validation of the telephone-administered PHQ-9 against the in-person administered SCID-I major depression module
AU - Fine, Thomas H.
AU - Contractor, Ateka A.
AU - Tamburrino, Marijo
AU - Elhai, Jon D.
AU - Prescott, Marta R.
AU - Cohen, Gregory H.
AU - Shirley, Edwin
AU - Chan, Philip K.
AU - Goto, Toyomi
AU - Slembarski, Renee
AU - Liberzon, Israel
AU - Galea, Sandro
AU - Calabrese, Joseph R.
N1 - Funding Information:
This project was funded by the Department of Defense Congressionally Directed Medical Research Program W81XWH-O7-1-0409, the “Combat Mental Health Initiative.” The sponsor had no role in study design, data collection, analysis, interpretation of results, report writing or manuscript submission.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2013/9/25
Y1 - 2013/9/25
N2 - Background: We assessed item-to-item correspondence between the Patient Health Questionnaire-9 (PHQ-9) and the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) major depression episode portion of the major depressive module. Method: Four hundred and ninety-eight soldiers in the Ohio National Guard were administered the PHQ-9 and SCID-I. Data were analyzed using chi-square analyses, logistic regression, receiver operating characteristic (ROC) curve analyses and diagnostic efficiency statistics. Results: To screen for depression effectively, results indicate use of the cardinal first two items, items representing fatigue, appetite and sleep changes with an item level cut-off point of two, and the item representing suicidal ideation with item level cut-off point of one. Further, total PHQ-9 scores significantly predicted SCID-I major depressive episode (MDE) and diagnosis (MDD) with moderate accuracy. Lastly, the cut-off total score of 10 had the optimal balance of sensitivity and specificity compared to other PHQ-9 scoring options. Limitations: Differences in timeline of administration of the measures, differences in "worst episode" reference between the measures, and use of a specific military population are some of the limitations. Conclusions: This validation study provides guidelines for the use of the telephone-administered PHQ-9 in assessing the lifetime prevalence of a major depressive episode and diagnosis in non-clinical populations, with implications for clinical use.
AB - Background: We assessed item-to-item correspondence between the Patient Health Questionnaire-9 (PHQ-9) and the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) major depression episode portion of the major depressive module. Method: Four hundred and ninety-eight soldiers in the Ohio National Guard were administered the PHQ-9 and SCID-I. Data were analyzed using chi-square analyses, logistic regression, receiver operating characteristic (ROC) curve analyses and diagnostic efficiency statistics. Results: To screen for depression effectively, results indicate use of the cardinal first two items, items representing fatigue, appetite and sleep changes with an item level cut-off point of two, and the item representing suicidal ideation with item level cut-off point of one. Further, total PHQ-9 scores significantly predicted SCID-I major depressive episode (MDE) and diagnosis (MDD) with moderate accuracy. Lastly, the cut-off total score of 10 had the optimal balance of sensitivity and specificity compared to other PHQ-9 scoring options. Limitations: Differences in timeline of administration of the measures, differences in "worst episode" reference between the measures, and use of a specific military population are some of the limitations. Conclusions: This validation study provides guidelines for the use of the telephone-administered PHQ-9 in assessing the lifetime prevalence of a major depressive episode and diagnosis in non-clinical populations, with implications for clinical use.
KW - Depression
KW - National guardsoldiers
KW - Patient Health Questionnaire-9
KW - Structured diagnostic interviews
UR - http://www.scopus.com/inward/record.url?scp=84888351521&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888351521&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2013.05.029
DO - 10.1016/j.jad.2013.05.029
M3 - Article
C2 - 23747208
AN - SCOPUS:84888351521
VL - 150
SP - 1001
EP - 1007
JO - J Affect Disord
JF - J Affect Disord
SN - 0165-0327
IS - 3
ER -